Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Mar 9;160(5):649–655.

Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal

A M Holbrook 1, R Crowther 1, A Lotter 1, C Cheng 1, D King 1
PMCID: PMC1230110  PMID: 10101999

Abstract

OBJECTIVE: To analyse the evidence for the efficacy and potential harmful effects of benzodiazepines compared with other therapies in the treatment of acute alcohol withdrawal. DATA SOURCES: MEDLINE and the Cochrane Controlled Trials Registry were searched for English-language articles published from 1966 to December 1997 that described randomized controlled trials (RCTs) of benzodiazepines in the treatment of acute alcohol withdrawal. Key words included "benzodiazepines" (exploded) and "randomized controlled trial." Bibliographies of relevant articles were reviewed for additional RCTs, and manufacturers of benzodiazepines were asked to submit additional RCT reports not in the literature. STUDY SELECTION: Articles were considered for the meta-analysis if they were RCTs involving patients experiencing acute alcohol withdrawal and comparing a benzodiazepine available in Canada with placebo or an active control drug. Of the original 23 trials identified, 11 met these criteria, representing a total of 1286 patients. DATA EXTRACTION: Data were extracted regarding the participants, the setting, details of the intervention, the outcomes (including adverse effects) and the methodologic quality of the studies. DATA SYNTHESIS: The meta-analysis of benefit (therapeutic success within 2 days) showed that benzodiazepines were superior to placebo (common odds ratio [OR] 3.28, 95% confidence interval [CI] 1.30-8.28). Data on comparisons between benzodiazepines and other drugs, including beta-blockers, carbamazepine and clonidine, could not be pooled, but none of the alternative drugs was found to be clearly more beneficial than the benzodiazepines. The meta-analysis of harm revealed no significant difference between benzodiazepines and alternative drugs in terms of adverse events (common OR 0.67, 95% CI 0.34-1.32) or dropout rates (common OR 0.68, 95% CI 0.47-0.97). INTERPRETATION: Benzodiazepines should remain the drugs of choice for the treatment of acute alcohol withdrawal.

Full Text

The Full Text of this article is available as a PDF (138.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates D. Another perspective on management of withdrawal. Can Fam Physician. 1997 Mar;43:421–424. [PMC free article] [PubMed] [Google Scholar]
  2. Baumgartner G. R., Rowen R. C. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med. 1987 Jul;147(7):1223–1226. [PubMed] [Google Scholar]
  3. Baumgartner G. R., Rowen R. C. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J. 1991 Mar;84(3):312–321. doi: 10.1097/00007611-199103000-00006. [DOI] [PubMed] [Google Scholar]
  4. Burroughs A. K., Morgan M. Y., Sherlock S. Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms. Alcohol Alcohol. 1985;20(3):263–271. [PubMed] [Google Scholar]
  5. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  6. Fleiss J. L. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2(2):121–145. doi: 10.1177/096228029300200202. [DOI] [PubMed] [Google Scholar]
  7. Foy A., March S., Drinkwater V. Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res. 1988 Jun;12(3):360–364. doi: 10.1111/j.1530-0277.1988.tb00208.x. [DOI] [PubMed] [Google Scholar]
  8. Fuller R. K., Gordis E. Refining the treatment of alcohol withdrawal. JAMA. 1994 Aug 17;272(7):557–558. [PubMed] [Google Scholar]
  9. Funderburk F. R., Allen R. P., Wagman A. M. Residual effects of ethanol and chlordiazepoxide treatments for alcohol withdrawal. J Nerv Ment Dis. 1978 Mar;166(3):195–203. doi: 10.1097/00005053-197803000-00005. [DOI] [PubMed] [Google Scholar]
  10. Gallant D. M., Bishop M. P., Camp E., Tisdale C. A six-month controlled evaluation of metronidazole (Flagyl) in chronic alcoholic patients. Curr Ther Res Clin Exp. 1968 Feb;10(2):82–87. [PubMed] [Google Scholar]
  11. Gallant D. M., Bishop M. P., Guerrero-Figueroa R., Selby M., Phillips R. Doxepin versus diazepam: a controlled evaluation in 100 chronic alcoholic patients. J Clin Pharmacol J New Drugs. 1969 Jan-Feb;9(1):57–65. [PubMed] [Google Scholar]
  12. Gawthrop P. Pharmacotherapy debate on alcohol withdrawal syndrome. Can Fam Physician. 1997 Jul;43:1209, 1211-2. [PMC free article] [PubMed] [Google Scholar]
  13. Glass R. M. Benzodiazepine prescription regulation. Autonomy and outcome. JAMA. 1991 Nov 6;266(17):2431–2433. [PubMed] [Google Scholar]
  14. Hasselblad V., McCrory D. C. Meta-analytic tools for medical decision making: a practical guide. Med Decis Making. 1995 Jan-Mar;15(1):81–96. doi: 10.1177/0272989X9501500112. [DOI] [PubMed] [Google Scholar]
  15. Hasselblad V., Mosteller F., Littenberg B., Chalmers T. C., Hunink M. G., Turner J. A., Morton S. C., Diehr P., Wong J. B., Powe N. R. A survey of current problems in meta-analysis. Discussion from the Agency for Health Care Policy and Research inter-PORT Work Group on Literature Review/Meta-Analysis. Med Care. 1995 Feb;33(2):202–220. [PubMed] [Google Scholar]
  16. Holbrook A. M., Crowther R., Lotter A., Cheng C., King D. Diagnosis and management of acute alcohol withdrawal. CMAJ. 1999 Mar 9;160(5):675–680. [PMC free article] [PubMed] [Google Scholar]
  17. Jadad A. R., Moore R. A., Carroll D., Jenkinson C., Reynolds D. J., Gavaghan D. J., McQuay H. J. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996 Feb;17(1):1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  18. Kaim S. C., Klett C. J., Rothfeld B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiatry. 1969 Jun;125(12):1640–1646. doi: 10.1176/ajp.125.12.1640. [DOI] [PubMed] [Google Scholar]
  19. Kolin I. S., Linet O. I. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol. J Clin Psychiatry. 1981 Apr;42(4):169–173. [PubMed] [Google Scholar]
  20. Kraus M. L., Gottlieb L. D., Horwitz R. I., Anscher M. Randomized clinical trial of atenolol in patients with alcohol withdrawal. N Engl J Med. 1985 Oct 10;313(15):905–909. doi: 10.1056/NEJM198510103131501. [DOI] [PubMed] [Google Scholar]
  21. Laird N. M., Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care. 1990;6(1):5–30. doi: 10.1017/s0266462300008916. [DOI] [PubMed] [Google Scholar]
  22. Lapierre Y. D., Bulmer D. R., Oyewumi L. K., Mauguin M. L., Knott V. J. Comparison of chlormethiazole (Heminevrin) and chlordiazepoxide (Librium) in the treatment of acute alcohol withdrawal. Neuropsychobiology. 1983;10(2-3):127–130. doi: 10.1159/000117998. [DOI] [PubMed] [Google Scholar]
  23. Lexchin J. Debating benzodiazepine use. Can Fam Physician. 1995 Aug;41:1293–1295. [PMC free article] [PubMed] [Google Scholar]
  24. Malcolm R., Ballenger J. C., Sturgis E. T., Anton R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May;146(5):617–621. doi: 10.1176/ajp.146.5.617. [DOI] [PubMed] [Google Scholar]
  25. Mayo-Smith M. F. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997 Jul 9;278(2):144–151. doi: 10.1001/jama.278.2.144. [DOI] [PubMed] [Google Scholar]
  26. McGrath S. D. A controlled trial of chlormethiazole and chlordiazepoxide in the treatment of the acute withdrawal phase of alcoholism. Br J Addict Alcohol Other Drugs. 1975 Apr;70 (Suppl 1):81–90. doi: 10.1111/j.1360-0443.1975.tb01340.x. [DOI] [PubMed] [Google Scholar]
  27. Mendels J., Wasserman T. W., Michals T. J., Fine E. W. Halazepam in the management of acute alcohol withdrawal syndrome. J Clin Psychiatry. 1985 May;46(5):172–174. [PubMed] [Google Scholar]
  28. Moher D., Fortin P., Jadad A. R., Jüni P., Klassen T., Le Lorier J., Liberati A., Linde K., Penna A. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet. 1996 Feb 10;347(8998):363–366. doi: 10.1016/s0140-6736(96)90538-3. [DOI] [PubMed] [Google Scholar]
  29. Mukherjee P. K. A comparison of the efficacy and tolerability of clobazam and chlordiazepoxide in the treatment of acute withdrawal from alcohol in patients with primary alcoholism. J Int Med Res. 1983;11(4):205–211. doi: 10.1177/030006058301100402. [DOI] [PubMed] [Google Scholar]
  30. Naranjo C. A., Sellers E. M., Chater K., Iversen P., Roach C., Sykora K. Nonpharmacologic intervention in acute alcohol withdrawal. Clin Pharmacol Ther. 1983 Aug;34(2):214–219. doi: 10.1038/clpt.1983.155. [DOI] [PubMed] [Google Scholar]
  31. O'Donovan M. C., McGuffin P. Short acting benzodiazepines. BMJ. 1993 Apr 10;306(6883):945–946. doi: 10.1136/bmj.306.6883.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Radouco-Thomas S., Garcin F., Guay D., Marquis P. A., Chabot F., Huot J., Chawla S., Forest J. C., Martin S., Stewart G. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(1-2):55–75. doi: 10.1016/0278-5846(89)90004-3. [DOI] [PubMed] [Google Scholar]
  33. Ritson B., Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. Drug Alcohol Depend. 1986 Dec;18(4):329–334. doi: 10.1016/0376-8716(86)90095-5. [DOI] [PubMed] [Google Scholar]
  34. Rosser W. W. Anxiety over benzodiazepines. Can Fam Physician. 1995 May;41:760, 763-5, 772-6. [PMC free article] [PubMed] [Google Scholar]
  35. Saitz R., Mayo-Smith M. F., Roberts M. S., Redmond H. A., Bernard D. R., Calkins D. R. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 1994 Aug 17;272(7):519–523. [PubMed] [Google Scholar]
  36. Sellers E. M. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management. CMAJ. 1988 Jul 15;139(2):113–120. [PMC free article] [PubMed] [Google Scholar]
  37. Sellers E. M., Naranjo C. A., Harrison M., Devenyi P., Roach C., Sykora K. Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther. 1983 Dec;34(6):822–826. doi: 10.1038/clpt.1983.256. [DOI] [PubMed] [Google Scholar]
  38. Sellers E. M., Zilm D. H., Degani N. C. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol. 1977 Nov;38(11):2096–2108. doi: 10.15288/jsa.1977.38.2096. [DOI] [PubMed] [Google Scholar]
  39. Shader R. I., Greenblatt D. J., Balter M. B. Appropriate use and regulatory control of benzodiazepines. J Clin Pharmacol. 1991 Sep;31(9):781–784. doi: 10.1002/j.1552-4604.1991.tb01910.x. [DOI] [PubMed] [Google Scholar]
  40. Stuppaeck C. H., Pycha R., Miller C., Whitworth A. B., Oberbauer H., Fleischhacker W. W. Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study. Alcohol Alcohol. 1992 Mar;27(2):153–158. [PubMed] [Google Scholar]
  41. Thompson W. L., Johnson A. D., Maddrey W. L. Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial. Ann Intern Med. 1975 Feb;82(2):175–180. doi: 10.7326/0003-4819-82-2-175. [DOI] [PubMed] [Google Scholar]
  42. Triazolam in the elderly. N Engl J Med. 1991 Dec 12;325(24):1742–1745. doi: 10.1056/NEJM199112123252412. [DOI] [PubMed] [Google Scholar]
  43. Wysowski D. K., Barash D. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System. Arch Intern Med. 1991 Oct;151(10):2003–2008. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES